ReviewHepatology international2018

Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis.

Alexander J Kovalic et al.PubMed ↗Publisher ↗

No numbers read from the abstract.